Revenue
$196m
-25.1% ↓ vs $261.8m
Revenue fell 25.1% and the dividend was pulled, while $23.1m of operating cash flow leaned on a $28.4m working-capital release.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY25 vs HY24
Revenue
$196m
-25.1% ↓ vs $261.8m
EBITDA
$0.56m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net profit after tax
−$10.4m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$23.1m
-40.2% ↓ vs $38.7m
Interim dividend per share
—
— vs 4.0c
Operating profit
−$10.9m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
−$14.3m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$17.5m
-33.3% ↓ vs $26.3m
What changed
PBT growth of -290.5% and NPAT growth of -294.4% sit only 3.9 percentage points apart, so the loss is an operating story, not a tax artefact (effective tax rate 27.1% vs 28.6%).
Operating cash flow fell 40.2% to $23.1m and cash on balance sheet declined to $17.5m from $26.3m, with no bank debt. No interim dividend was declared; the prior interim was 4.0 cents per share. An acquisition was announced alongside the result, to be funded 70% debt and 30% equity with completion expected May 2025.
What matters
EBITDA at $0.6m on $196.0m of revenue means the cost base is barely being covered, and the loss below the EBITDA line absorbs depreciation, amortisation and interest in full. A $5m cost-out programme is referenced in the release but is not quantified into a run-rate, so it is not yet enough to close the gap to HY24 profitability.
The cash result is flattered by destocking, not earnings. Inventory fell $19.0m and trade debtors fell $12.7m, contributing to a $28.4m reduction in operating working capital. That is the bulk of the $23.1m OCF and explains why FCF pre-lease was $19.3m against a $10.4m net loss (FCF/NPAT -185.3%). Cash conversion at the headline OCF/EBITDA level (4,127.6% vs 182.6%) is mathematically distorted by the near-zero EBITDA denominator and should not be read as cash-quality strength.
Capital allocation is being reset around the acquisition. The interim dividend was suspended (prior payout was 125.0% of NPAT) and the deal will introduce debt onto a previously unlevered balance sheet. With $17.5m of cash and a $100m facility, funding capacity exists, but the equity component and the loss of dividend income change the shareholder return profile.
Expectations
Under the FY24 split, HY24 represented 54.6% of full-year revenue and 67.5% of full-year EBITDA, implying that the second half was already weaker last year ($217.4m revenue, $10.2m EBITDA, -$2.7m NPAT). Annualising HY25 revenue gives $392.1m, roughly 18% below FY24, and EBITDA at $0.6m provides almost no cushion to absorb a typically softer second half.
The release frames the period as positioning for a demand recovery rather than calling its timing. On the supplied data, the gap between current run-rate and prior profitability is wide enough that a recovery would need to combine the flagged $5m cost-out with a volume rebound to restore HY24-level earnings.
Quality of result
Revenue contraction of 25.1% has flowed almost entirely through to operating profit, taking EBIT to -$10.9m from $10.2m, which points to fixed-cost deleverage rather than a margin or mix issue alone. ROE moved to -5.6% from +2.6%, and equity declined $22.0m to $185.2m.
Cash flow looks superficially resilient but is timing-driven. The $28.4m working-capital release is essentially a one-time benefit from a lower revenue base, and inventory days actually rose to 102 from 89.5 even as the dollar balance fell to $109.6m, indicating slower inventory turn rather than tighter discipline. Receivable days were broadly flat at 39 versus 38. Once destocking normalises, OCF will need to come from earnings, and on current EBITDA there is little to come from.
Unresolved
This briefing cannot assess current-period segment performance, acquisition financial metrics, or any management view on FY25 earnings because none of those are present in the supplied data.
Chat
Ask follow-up questions about Steel & Tube Holdings's HY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Steel & Tube - 1H25 Results Announcement
HY25 / results announcementSteel & Tube - 1H25 Results Media Release
HY25 / media releaseSteel & Tube - 1H25 Results Presentation
HY25 / results presentationSteel & Tube 1H25 Interim Report
HY25 / financial reportSteel & Tube 1H24 Interim Report
HY24 / financial reportSteel & Tube 1H24 Results Announcement
HY24 / results announcementSteel & Tube 1H24 Results Media Release
HY24 / media releaseSteel & Tube - FY24 Annual Report
FY24 / financial reportSteel & Tube - FY24 Results Announcement
FY24 / results announcementSteel & Tube - FY24 Results Announcement
FY24 / results releaseSteel & Tube - Trading Update - November 2024
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Revenue growth context
Revenue growth was -25.1% for this reporting period.
Working-capital pressure
Inventory days were 102 days, +13 days versus the prior comparable period.
Leverage and balance-sheet risk
Net debt / EBITDA is -31.20x, -30.00x versus the prior comparable period.
Get the next Steel & Tube Holdings briefing and related NZX reporting-season updates by email.